Description

OA Molecular Oncology is a multidisciplinary open access 'peer reviewed' journal that publishes basic and clinical research concerning all aspects of clinical and molecular oncology including:

Key Biological Processes    Biomarkers    Emerging Technologies    Infrastructures

Cancer Genetics & Genomic Instability      Minimal Residual & Premalignant Disease

Cancer Microenvironment      Molecular Pathology      Tumour Immunology

Cancer Therapy    Clinical Pharmacology    Chemotherapy, Radiotherapy & Surgery

Epidemiology & Prevention      Clinical Trials

 

OA Molecular Oncology is committed to publishing high quality 'peer reviewed' manuscripts that illustrate the most important and 'cutting edge' developments in all areas of clinical and molecular oncology (including radiotherapy, chemotherapy, target therapies…etc.).

 

OA Molecular Oncology aims to:

Promote academic dialogue by facilitating international exchange and stimulating fair debate.

Further advance the discipline.

Highlight significant advances in the field.

Provide a focus for research and development.

Challenge pre-conceived and untested ideas within the subject.

Revisit old controversies with new insights.

Educate and promote good practice and disseminate the latest experimental and practical techniques.

Encourage ethical research and transparency in publication by adhering to the Association for Medical Ethics (AME) Ethical Rules of Disclosure.

Provide a forum for exciting findings in the field of clinical and molecular oncological research and encompasses basic, translational, and clinical research in all molecular oncology -related disciplines, with a particular focus on minimally invasive procedures.

Bring together knowledge from the different specialties involved in this very broad discipline, from the bench to the bedside and in practice.

 

OA Molecular Oncology is devoted to the rapid dissemination of original works on principles, development, and applications within clinical and molecular oncology.

 

We encourage biomedical researchers in all fields to publish results that challenge current models, doctrine or dogmas.

 

The primary objective of the journal is to serve the needs of this diverse community of researchers, providing a forum for prompt communication of original and innovative research findings that have relevance to clinical and molecular oncology.

 

We would hope to provide a forum for true translational research where findings can be applied from 'bench to bedside' for the benefit of global health.

 

The wide scope of the journal reflects the broad and rapidly expanding nature of the field of clinical and molecular oncology.

ISSN 2052-9635